Serina CEO granted 380,825 stock options at $1.89
Serina Therapeutics Chief Executive Officer Steven A. Ledger received a grant of stock options for 380,825 shares of Common Stock at an exercise price of $1.89 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Serina Therapeutics Chief Executive Officer Steven A. Ledger received a grant of stock options for 380,825 shares of Common Stock at an exercise price of $1.89 per share. These options expire on May 21, 2036 and vest over four years, with 12/48ths vesting after 12 months and the remainder vesting in equal monthly installments.
Insider Trade Summary
Grant/Award: 380,825 shares
Grant/Award
1 txn
Insider
LEDGER STEVEN A
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 380,825 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 380,825 contracts (Direct)
Footnotes (1)
- F1. Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested.
Key Figures
Options granted: 380,825 options
Exercise price: $1.89 per share
Expiration date: May 21, 2036
+2 more
5 metrics
Options granted
380,825 options
Stock Option (right to buy) grant on May 21, 2026
Exercise price
$1.89 per share
Conversion/exercise price for granted options
Expiration date
May 21, 2036
Option term end for CEO grant
Shares underlying options
380,825 shares
Underlying Common Stock for granted options
Post-transaction derivative holdings
380,825 options
Total options held after this grant
Key Terms
Stock Option (right to buy), Common Stock, exercise price, Vesting Commencement Date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
exercise price financial
"conversion_or_exercise_price: 1.8900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Vesting Commencement Date financial
"twelve months after the Vesting Commencement Date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
vest financial
"shall vest on the same calendar day of each subsequent month"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Serina Therapeutics (SER) CEO Steven A. Ledger report on this Form 4?
Steven A. Ledger reported receiving a grant of stock options for 380,825 shares of Serina Therapeutics Common Stock. These compensation-related options give him the right to buy shares at a fixed price, rather than reflecting an open-market purchase or sale.
How many Serina Therapeutics (SER) stock options were granted to the CEO?
The CEO received 380,825 stock options linked to Serina Therapeutics Common Stock. Each option represents the right to buy one share, providing potential equity exposure if the share price exceeds the fixed $1.89 exercise price in the future.
What is the exercise price and expiration date of the Serina Therapeutics (SER) CEO’s options?
The options have an exercise price of $1.89 per share and expire on May 21, 2036. This means the CEO can choose to buy shares at $1.89 any time before that expiration date, subject to the options having vested.
How do the Serina Therapeutics (SER) CEO’s stock options vest over time?
According to the filing, 12/48ths of the options vest twelve months after the Vesting Commencement Date. The remaining 36/48ths vest in equal 1/48th monthly installments on the same calendar day thereafter until all 380,825 options are fully vested.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates